MEDICINAL PLANTS IN PARKINSON’S DISEASE TREATMENT: A BRIEF REVIEW OF THE RECENT DATA
AbstractParkinson’s disease (PD) is a common neurodegenerative disorder that affects approximately 2% of the population aged over 65. Dopamine precursor L-3,4-dihydroxyphenylalanine (L-DOPA) is the main treatment to provide symptomatic relief for Parkinson’s disease (PD). However, with long-term administration of L-DOPA, as many as 95% of patients develop several complications. Medicinal plants (MP) and their active components have been used throughout the worldfor the management and treatment of several diseases such as PD. The World Health Organization (WHO) estimates that 80% of population in developing countries, particularly in Africa, use traditional medicine due to financial constraints. Thus, the use of medicinal plants represents the therapeutic response for populations who have difficulty accessing modern drugs and a source of income. Several MP have been administered over a long period, and they have been proven to cure PD. Therefore, this review provides a summary of recent advance of MPand their bioactive compounds involved in the treatment of PD from the year 2018up to now.
Article Information
8
4756-4763
496 KB
304
English
IJPSR
Adjia Hamadjida *, Rigobert Espoir Ayissi Mbomo, Fidèle Ntchapda and Jean Pierre Kilekoung Mingoas
Department of Neuroscience, University of Montreal, Montreal, Canada.
hamadjia@gmail.com
06 February 2023
02 May 2023
31 May 2023
10.13040/IJPSR.0975-8232.14(10).4756-63
01 October 2023
Download